Heba Ahmed is an accomplished regulatory affairs specialist with over a decade of experience in the medical device sector, currently serving as the Manager of Administration of In Vitro Diagnostic (IVD) Listing at the Egyptian Drug Authority (EDA). She has made significant contributions to regulatory practices, particularly in the field of IVD medical devices, where her work focuses on IVD dossier review, assessment, and market authorization.

Heba’s journey in the healthcare field began with her Bachelor of Pharmaceutical Sciences from Cairo University in 2008, where she graduated with honors. She quickly established herself in regulatory affairs, starting her career in 2009 at the Central Administration of Pharmaceutical Affairs (CAPA) under Egypt’s Ministry of Health.

Her work at EDA began in 2020, where she initially handled regulatory approvals for imported medical devices before transitioning to leadership positions within the IVD sector.

Her dedication and leadership qualities earned her the position of Manager of Imported IVD Listing Unit in 2021, and later, in November 2022, she became the Manager of the Administration of IVD Listing, overseeing all aspects of IVD market authorization in Egypt. Throughout her career, Heba has demonstrated a keen ability to manage teams, troubleshoot complex regulatory challenges, and introduce innovative concepts to improve processes.